The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 13.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158.
DXP Enterprises, Inc.
DXPE · Nasdaq · USD · Market cap $2.9B · 3,286 employees
DXP Enterprises, Inc., together with its subsidiaries, engages in distributing maintenance, repair, and operating (MRO) products, equipment, and services in the United States, Canada, and internationally.
FAIL · Does not pass the screenScreen close, 2026-09-21 · not a live quote
Screened 2026-09-21 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 188.19 against the desk's fair-value range, base estimate 176.60, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
DXP Enterprises, Inc. holds its Markdown at $188.19. The statistical read favours the sellers, held for 10 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 10 days |
| Price at the screen | $188.19 |
| Valuation | 33.13 trailing · 24.57 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.03 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 53.62% | Below 33% | Interest-bearing debt is 53.6% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 41.62% | Below 49% | Money owed to the company is 41.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.18% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 6.2% above the base estimate.
Third-party analyst targets: 2 covering, consensus None. The average target sits +6% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsIndustrial distributor priced above its fair value
Every factory floor that needs a seal, pump or bearing at short notice relies on a specialist like DXP to keep machines turning. Yet the shares trade 8 percent above our fair value with a forward multiple of 22 times earnings, despite revenue growth of only 10 percent and thin 4 percent profit margins. The business clears our ethical screen, but that alone does not justify stretching the valuation.
The return on equity reaches 18 percent, yet the moat remains unknown and two analysts offer no clear consensus. Industrial distribution tends to track the broader economy, so current earnings may already reflect peak demand rather than a durable advantage. Paying a premium for modest growth leaves little room for disappointment.
Risk sits in the cyclical exposure and limited pricing power that can compress margins when volumes fall. Currency moves and supply-chain shocks add further volatility. Analysis, not advice.
| Forward P/E | 24.6xpriced for continued growth |
| Trailing P/E | 33.1xa premium valuation |
| EPS, trailing | 5.68 |
| EPS, forward | 7.66 |
| Revenue growth | +15.6%steady growth |
| Profit margin | 4.4%barely profitable |
| Return on equity | 18.5%a solid return on shareholder capital |
| FCF yield | 2.65% |
| Debt to equity | 1.66a meaningful debt load worth watching |
| Current ratio | 2.99comfortably covers its short-term bills |
| Beta | 1.03moves a little more than the market |
| Short interest, float | 0.04% |
| 52-week range | 84.04 - 208.00 |
| Market cap | $2.9B |
| Employees | 3,286 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDXPE trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 99%. Our forward projection puts the odds of a 10% gain over the next month near 40%. The street (2 analysts) rates it none, with a mean price target of $158.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 Market-Beating Stocks on Our Watchlist StockStory · 7d ago
- 1 Small-Cap Stock with Exciting Potential and 2 We Turn Down StockStory · 19d ago
- 1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm StockStory · 27d ago
- 3 Reasons DXPE Has Explosive Upside Potential StockStory · 18 Aug 2026
- 5 Revealing Analyst Questions From DXP’s Q2 Earnings Call StockStory · 14 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $149.15 | +7.3% | · | $1,073 | +7.3% |
| 2 months | $153.56 | +4.2% | · | $1,042 | +4.2% |
| 3 months | $130.94 | +22.2% | · | $1,222 | +22.2% |
| 6 months | $108.65 | +47.2% | · | $1,472 | +47.2% |
| 1 year | $80.50 | +98.7% | · | $1,987 | +98.7% |
| 2 years | $47.49 | +236.9% | · | $3,369 | +236.9% |
| 3 years | $35.72 | +347.9% | · | $4,479 | +347.9% |
| 5 years | $32.49 | +392.4% | · | $4,924 | +392.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DXPE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.